# Biora Therapeutics Inc. (BIOR)

Source: https://www.quantisnow.com/company/BIOR
Generated: 2026-11-11T20:12:12.154Z

- Ticker: BIOR
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2020
- Website: https://www.bioratherapeutics.com

## About

Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ingestible capsule for needle-free delivery of biotherapeutics directly into the intestinal mucosa for enhanced systemic uptake. It is also developing diagnostics devices to help characterize the GI tract and diagnose GI diseases, such as small intestine bacterial overgrowth through the development of various technologies to diagnose at the site of the disease. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.

## Latest BIOR news and filings

- 2025-03-31 12:00 UTC [Biora Therapeutics Successfully Completes Restructuring Process](https://www.quantisnow.com/insight/biora-therapeutics-successfully-completes-restructuring-process-5966075)
- 2024-12-30 13:07 UTC [SEC Form 8-K] [Biora Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Events That Accelerate or Increase a Direct Financial Obligation, Financial Statements and Exhibits](https://www.quantisnow.com/insight/biora-therapeutics-inc-filed-sec-form-8-k-entry-into-a-5826533)
- 2024-12-30 13:00 UTC [Biora Therapeutics Undertakes Chapter 11 Sale Process to Position Business for Future Growth](https://www.quantisnow.com/insight/biora-therapeutics-undertakes-chapter-11-sale-process-to-position-business-5826485)
- 2024-12-17 00:32 UTC [SEC Form 4] [SEC Form 4 filed by Director Athyrium Opportunities Iii Co-Invest 1 Lp](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-athyrium-opportunities-iii-co-invest-5815626)
- 2024-12-10 12:00 UTC [SEC Form 8-K] [SEC Form 8-K filed by Biora Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-biora-therapeutics-inc-5806607)
- 2024-11-15 21:05 UTC [SEC Form 8-K] [SEC Form 8-K filed by Biora Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-biora-therapeutics-inc-5778736)
- 2024-11-14 21:10 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Biora Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-biora-therapeutics-inc-5775844)
- 2024-11-14 21:05 UTC [SEC Form 8-K] [Biora Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/biora-therapeutics-inc-filed-sec-form-8-k-results-of-operations-5775607)
- 2024-11-14 15:01 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Biora Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-biora-therapeutics-inc-5773847)
- 2024-11-14 13:00 UTC [Earnings Date] [Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results](https://www.quantisnow.com/insight/biora-therapeutics-provides-corporate-update-and-reports-third-quarter-2024-5773351)
- 2024-11-07 21:30 UTC [Earnings Date] [Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update](https://www.quantisnow.com/insight/biora-therapeutics-to-report-third-quarter-2024-financial-results-and-5759746)
- 2024-10-29 20:43 UTC [SEC Form 8-K] [Biora Therapeutics Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Entry into a Material Definitive Agreement](https://www.quantisnow.com/insight/biora-therapeutics-inc-filed-sec-form-8-k-unregistered-sales-of-5742115)
- 2024-10-29 12:37 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Biora Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-biora-therapeutics-inc-5741124)
- 2024-10-29 12:28 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Biora Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-biora-therapeutics-inc-5741066)
- 2024-10-29 12:24 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Biora Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-biora-therapeutics-inc-5741062)
- 2024-10-29 12:21 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Biora Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-biora-therapeutics-inc-5741059)
- 2024-10-29 12:19 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Biora Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-biora-therapeutics-inc-5741057)
- 2024-10-29 12:15 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Biora Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-biora-therapeutics-inc-5741052)
- 2024-10-29 12:00 UTC [Public Offering] [Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules](https://www.quantisnow.com/insight/biora-therapeutics-announces-3-million-registered-direct-offering-priced-at-the-market-5740936)
- 2024-10-28 12:00 UTC [Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting](https://www.quantisnow.com/insight/biora-therapeutics-shares-progress-on-smaller-biojet-clinical-device-with-5739392)
- 2024-10-23 21:24 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Biora Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-biora-therapeutics-inc-5735708)
- 2024-10-14 12:00 UTC [Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting](https://www.quantisnow.com/insight/biora-therapeutics-to-reveal-00-size-biojet-device-at-the-14th-5724042)
- 2024-10-11 20:52 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Biora Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-biora-therapeutics-inc-5723665)
- 2024-10-11 12:00 UTC [SEC Form 8-K] [Biora Therapeutics Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/biora-therapeutics-inc-filed-sec-form-8-k-material-modification-to-5723053)
- 2024-10-09 21:40 UTC [SEC Schedule 13D] [Amendment: SEC Form SC 13D/A filed by Biora Therapeutics Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13da-filed-by-biora-therapeutics-inc-5721432)
- 2024-10-07 20:45 UTC [SEC Form 8-K] [Biora Therapeutics Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Entry into a Material Definitive Agreement](https://www.quantisnow.com/insight/biora-therapeutics-inc-filed-sec-form-8-k-creation-of-a-5718561)
- 2024-10-07 12:00 UTC [Conference Announcement] [Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium](https://www.quantisnow.com/insight/biora-therapeutics-to-present-at-the-19th-annual-peptide-therapeutics-5717858)
- 2024-09-30 12:00 UTC [Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024](https://www.quantisnow.com/insight/biora-therapeutics-announces-award-winning-abstract-to-be-presented-at-american-5707855)
- 2024-09-16 20:30 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Biora Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-biora-therapeutics-inc-5695238)
- 2024-09-13 20:05 UTC [SEC Form 8-K] [Biora Therapeutics Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Entry into a Material Definitive Agreement](https://www.quantisnow.com/insight/biora-therapeutics-inc-filed-sec-form-8-k-creation-of-a-5693309)
- 2024-09-13 14:37 UTC [SEC Schedule 13D] [Amendment: SEC Form SC 13D/A filed by Biora Therapeutics Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13da-filed-by-biora-therapeutics-inc-5693095)
- 2024-09-09 12:00 UTC [Biora Therapeutics Achieves ISO 13485 Certification](https://www.quantisnow.com/insight/biora-therapeutics-achieves-iso-13485-certification-5686677)
- 2024-09-05 10:02 UTC [SEC Form 8-K] [SEC Form 8-K filed by Biora Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-biora-therapeutics-inc-5683148)
- 2024-09-04 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Biora Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-biora-therapeutics-inc-5680799)
- 2024-09-03 20:31 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Biora Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-biora-therapeutics-inc-5680164)
- 2024-08-28 12:00 UTC [Biora Therapeutics Announces Positive Nasdaq Listing Decision](https://www.quantisnow.com/insight/biora-therapeutics-announces-positive-nasdaq-listing-decision-5674323)
- 2024-08-26 12:00 UTC [Conference Announcement] [Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference](https://www.quantisnow.com/insight/biora-therapeutics-to-present-at-hc-wainwright-26th-annual-global-5671335)
- 2024-08-23 21:13 UTC [SEC Form S-3] [SEC Form S-3 filed by Biora Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-biora-therapeutics-inc-5670933)
- 2024-08-23 21:11 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Biora Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-biora-therapeutics-inc-5670927)
- 2024-08-23 21:08 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Biora Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-biora-therapeutics-inc-5670916)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BIOR
- Earnings history: https://www.quantisnow.com/earnings/BIOR
- Dividend history: https://www.quantisnow.com/dividends/BIOR
- Insider transactions: https://www.quantisnow.com/insiders/BIOR
- Options chain: https://www.quantisnow.com/options/BIOR
- SEC 8-K filings only: https://www.quantisnow.com/company/BIOR/8-k
- RSS and alerts for BIOR: https://www.quantisnow.com/docs/rss-feeds.md